Resolution of symptoms · non‐allergic rhinitis
Capsaicin may leads to higher daily record chart symptom resolution 4 weeks post‐treatment… compared with placebo (low certainty).
1 finding from 1 review
Overall nasal symptom score 36 weeks post‐treatment · non‐allergic rhinitis
1 finding from 1 review
Treatment‐related adverse events · non‐allergic rhinitis
The review found no eligible studies for this question.
1 finding from 1 review
Nasal obstruction during the 4th week of treatment Number of responders · patients with non‐allergic rhinitis
Capsaicin showed no clear difference in nasal obstruction during the 4th week of treatment Number of… compared with budesonide (low certainty).
1 finding from 1 review
Aggregate relief score during the 4th week of treatment · patients with non‐allergic rhinitis
1 finding from 1 review
Treatment‐related adverse events · patients with non‐allergic rhinitis
The review found no eligible studies for this question.
1 finding from 1 review
Smell testing University of Pennsylvania Smell Identification Test (UPSIT) Scale from: 0 to 40 · patients with non‐allergic rhinitis
1 finding from 1 review
Treatment‐related adverse events · patients with non‐allergic rhinitis
The review found no eligible studies for this question.
1 finding from 1 review
Pain (% reduction from baseline) VAS 100mm · patients with Knee pain in patients with rheumatoid arthritis
2 findings from 1 review
Substantial benefit · adults with postherpetic neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
PGICvery much improved, week 8 and week 12 · adults with postherpetic neuralgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Moderate benefit · adults with postherpetic neuralgia
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Patient Global Impression of Change much or very much improved · adults with postherpetic neuralgia
2 findings from 1 review
Lack of efficacy withdrawal · adults with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · adults with postherpetic neuralgia
1 finding from 1 review
Serious adverse events · adults with postherpetic neuralgia
1 finding from 1 review
Death · adults with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
1 finding from 1 review
Pain on daily activity (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Topical capsaicin (0.025% cream) showed no clear difference in pain on daily activity (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review
Maximum pain while on medication (VAS) · Adult patients aged >=18 years, clinically or radiographically diagnosed with TMD (McNeill 1997 criteria); moderate to severe pain of…
Topical capsaicin (0.025% cream) showed no clear difference in maximum pain while on medication (VAS) compared with placebo; GRADE not reported.
1 finding from 1 review